Almac Commits $48M to Advance Integrated eClinical Technologies

Almac Clinical Technologies was featured in Fierce Biotech discussing our $48 million investment to advance integrated eClinical technologies.

As part of this investment, we’ve launched Almac Trial Coordinator™ , our unified, protocol-driven solution designed to bring together operational processes, clinical data, and systems into one streamlined framework. Read the article to learn how we are solving system fragmentation and empowering modern clinical trials.